These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clinical pharmacology of tobramycin. Horikoshi N; Valdivieso M; Bodey GP Am J Med Sci; 1973 Dec; 266(6):453-8. PubMed ID: 4774079 [No Abstract] [Full Text] [Related]
45. [Pseudomonas aeruginosa: antibiotic sensitivity and serotyping]. Chiaradia V; Santini G G Ital Chemioter; 1987; 34(1-3):19-22. PubMed ID: 3143616 [No Abstract] [Full Text] [Related]
46. [Surface changes of Pseudomonas caused by aminoglycoside antibiotics]. Utsui S; Nishino T; Nakazawa S Nihon Saikingaku Zasshi; 1975 Jan; 30(1):107. PubMed ID: 814340 [No Abstract] [Full Text] [Related]
47. [Comparative sensitivity of Pseudomonas aeruginosa to aminosides]. Michel-Briand Y; Dupont MJ; Robert V Nouv Presse Med; 1979 Oct; 8(42):3407-12. PubMed ID: 119948 [No Abstract] [Full Text] [Related]
48. The effect of tobramycin on rabbit eyes. Purnell WD; McPherson SD Am J Ophthalmol; 1974 Apr; 77(4):578-82. PubMed ID: 4206620 [No Abstract] [Full Text] [Related]
49. Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Westenfelder SR; Welling G; Madsen PO Infection; 1974; 2(2):76-9. PubMed ID: 4842961 [No Abstract] [Full Text] [Related]
51. Short term routine antibiotic prophylaxis in surgery. Stokes EJ; Waterworth PM; Franks V; Watson B; Clark CG Br J Surg; 1974 Sep; 61(9):739-42. PubMed ID: 4213380 [No Abstract] [Full Text] [Related]
52. Pharmacokinetics and side-effects of gentamicin in healthy and pseudomonas aeruginosa infected sheep. Lashev L; Lasarova S J Vet Pharmacol Ther; 2001 Jun; 24(3):237-40. PubMed ID: 11442805 [No Abstract] [Full Text] [Related]
53. The cation problem and susceptibility testing. Lewis JF Am J Clin Pathol; 1981 Oct; 76(4):508-9. PubMed ID: 6794353 [No Abstract] [Full Text] [Related]
54. Serum levels of gentamicin and tobramycin after slow intravenous bolus injection. Stratford BC; Dixson S; Cobcroft AJ Lancet; 1974 Mar; 1(7854):378-9. PubMed ID: 4131032 [No Abstract] [Full Text] [Related]
55. [Comparison of kinetics and effectiveness against pseudomonas aeruginosa between intravenously and intramuscularly administered tobramycin; experimental study using diffusion chambers incubated in rabbit's peritoneal cavity (author's transl)]. Jozaki K; Yamashita N; Sunakawa K; Hattori H; Iwata S; Iwasaki Y; Kanemitsu T; Ichihashi Y Kansenshogaku Zasshi; 1981 Sep; 55(9):630-6. PubMed ID: 6798147 [No Abstract] [Full Text] [Related]
56. Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity. Takahashi Y; Umemura E; Kobayashi Y; Murakami S; Nawa T; Morinaka A; Miyake T; Shibasaki M J Antibiot (Tokyo); 2018 Feb; 71(2):345-347. PubMed ID: 28655929 [No Abstract] [Full Text] [Related]
57. Pharmacologic studies on tobramycin and comparison with gentamicin. Meyers BR; Hirschman SZ J Clin Pharmacol New Drugs; 1972; 12(8):321-4. PubMed ID: 4484032 [No Abstract] [Full Text] [Related]
58. Quantitative antibiogram as a potential tool for epidemiological typing. Flournoy DJ Infect Control; 1982; 3(5):384-7. PubMed ID: 6813282 [No Abstract] [Full Text] [Related]